Is blood eosinophilia a treatable trait in chronic obstructive airway diseases? [PDF]
Massetti G +4 more
europepmc +1 more source
The Clinical and Economic Impact of Biologic Agents in Asthma Management: a Systematic Review. [PDF]
Procacci C +5 more
europepmc +1 more source
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial. [PDF]
Diab N +16 more
europepmc +1 more source
Mepolizumab as a Possible Treatment for Eosinophilic Ureteritis. [PDF]
Sheth H +4 more
europepmc +1 more source
Neoplasm Adverse Events Associated With Anti-Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study. [PDF]
Lyu W +9 more
europepmc +1 more source
Real-World Effectiveness of MEpolizuMaB in Eosinophilic Granulomatosis with Polyangiitis in Greece: A Protocol for a Multicentre Retrospective Observational Study - The MEMBER Study. [PDF]
Koutsianas C +11 more
europepmc +1 more source
Glucocorticoid discontinuation in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: associations with tapering patterns and initiation timing. [PDF]
Yamane T +4 more
europepmc +1 more source
A case of herpes zoster following the first dose of benralizumab. [PDF]
Aksu K +5 more
europepmc +1 more source
Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study. [PDF]
Zheng W +4 more
europepmc +1 more source
Blood eosinophil count as a biomarker for therapy guidance in COPD and asthma exacerbations. [PDF]
Godallage AN +5 more
europepmc +1 more source

